Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan
Respirology · 2024-06 · 29 (6) · 455-457
DOI: 10.1111/resp.14729 ↗Kurz gefasst
Leserbrief in der Zeitschrift Respirology, online erschienen am 23.04.2024. Verfasst von Keiko Kan-O. Beteiligte Einrichtung: Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Asthma, Biological Products. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
with higher asthma-related death rates, we observed that the number of patients with prescribed biologics per 100,000 population tended to be lower.Given that both biologic prescriptions and asthma-related deaths are prevalent among older adults, rectifying specialist imbalances and addressing regional disparities in severe asthma management might be crucial for achieving the 'zero death from asthma strategy'.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
ORCID-Profile: Keiko Kan-O
Zitieren
APA
Kan-O, K. (2024). Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan. Respirology, 29(6), 455-457. https://doi.org/10.1111/resp.14729
Vancouver
Kan-O K. Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan. Respirology. 2024;29(6):455-457. doi:10.1111/resp.14729
BibTeX
@article{KanO2024,
author = {Kan-O, Keiko},
title = {Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan},
journal = {Respirology},
year = {2024},
volume = {29},
number = {6},
pages = {455--457},
doi = {10.1111/resp.14729}
}
EUVIMED